# Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

> **NCT03606824** · NA · UNKNOWN · sponsor: **Shaochun.Li** · enrollment: 248 (estimated)

## Conditions studied

- Dyslipidemia
- Subclinical hypothyroïdism
- Statin
- ASCVD

## Interventions

- **DRUG:** Pitavastatin and placebo
- **DRUG:** Pitavastatin and levothyroxine

## Key facts

- **NCT ID:** NCT03606824
- **Lead sponsor:** Shaochun.Li
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-25
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-05-31
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2019-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606824, "Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03606824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*